A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers

NCT01612806 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped Site selection

Conditions

Venous Stasis Ulcer

Interventions

DEVICE: PriMatrix
DEVICE: PriMatrix Ag
PROCEDURE: moist wound therapy

Sponsor

Integra LifeSciences Corporation